汇添富国证港股通创新药ETF
Search documents
12月23日港股通创新药ETF工银(159217)遭净赎回2524.06万元
Xin Lang Cai Jing· 2025-12-24 02:50
来源:新浪基金∞工作室 数据显示,12月23日,港股通创新药ETF工银(159217)遭净赎回2524.06万元,位居当日跨境ETF净流出 排名7/202。最新规模50.78亿元,前一日规模51亿元,当日资金净流出额占前一日规模的比例为 0.49%。 近5日,港股通创新药ETF工银(159217)遭净赎回2788.94万元,位居跨境ETF净流出排名第11/202。近10 日,港股通创新药ETF工银(159217)遭净赎回3058.09万元,位居跨境ETF净流出排名第14/202。近20 日,港股通创新药ETF工银(159217)遭净赎回5892.89万元,位居跨境ETF净流出排名第11/202。 港股通创新药ETF工银(159217)成立于2025年3月26日,基金全称为工银瑞信国证港股通创新药交易 型开放式指数证券投资基金,基金简称为港股通创新药ETF工银。该基金管理费率每年0.40%,托管费 率每年0.07%。港股通创新药ETF工银(159217)跟踪标的指数为港股通创新药(987018)。 规模方面,截止12月23日,港股通创新药ETF工银(159217)最新份额为38.25亿份,最新规模为50.78 ...
12月15日港股通创新药ETF工银(159217)遭净赎回133.43万元
Xin Lang Cai Jing· 2025-12-16 02:13
流动性方面,截止12月15日,港股通创新药ETF工银(159217)近20个交易日累计成交金额108.35亿 元,日均成交金额5.42亿元; 港股通创新药ETF工银(159217)现任基金经理为刘伟琳、焦文龙。刘伟琳自2025年3月26日管理(或 拟管理)该基金,任职期内收益31.62%;焦文龙自2025年4月10日管理(或拟管理)该基金,任职期内 收益50.01%。 来源:新浪基金∞工作室 数据显示,12月15日,港股通创新药ETF工银(159217)遭净赎回133.43万元,位居当日跨境ETF净流出排 名15/200。最新规模50.62亿元,前一日规模53.04亿元,当日资金净流出额占前一日规模的比例为 0.03%。 近5日,港股通创新药ETF工银(159217)遭净赎回269.15万元,位居跨境ETF净流出排名第34/200。近10 日,港股通创新药ETF工银(159217)遭净赎回2672.71万元,位居跨境ETF净流出排名第11/200。近20 日,港股通创新药ETF工银(159217)获净申购1.02亿元,位居跨境ETF净流入排名第51/200。 港股通创新药ETF工银(159217)成立于202 ...
公募机构“瞄准”港股机遇
Zheng Quan Ri Bao· 2025-12-14 16:18
本报记者 昌校宇 近期港股市场虽经历调整,却逆势激发资金布局热情。多家公募机构积极行动,不仅缩短新基金募集期,更有新上市的交 易型开放式指数基金(ETF)产品快速建仓,彰显出机构对港股后市投资机会的乐观预期。 新成立的港股主题ETF同样展现出积极入市的姿态。以定于12月15日上市的汇添富恒指港股通ETF为例,该基金上市交易 公告书披露的基金资产组合数据显示,截至12月8日,其权益资产占基金净值的比例已接近70%,建仓速度较快。 12月份以来,多家公募机构陆续宣布旗下港股主题基金提前结束募集,部分产品甚至将原定长达数月的发行期压缩至数 天。 例如,路博迈基金于12月9日发布公告称,旗下路博迈港股通科技股票基金的募集截止日,从原定的2026年3月6日提前至 2025年12月26日,发行期明显缩短。鹏扬基金也在12月10日宣布,将旗下鹏扬港股通精选混合基金的募集截止日从2026年1月 19日调整至2025年12月12日。更有多只基金采取"闪电发行"模式,如富国基金将旗下富国港股精选混合(QDII)原定12天的募 集期缩减至仅3天,于12月10日便宣告募集结束。 华夏基金相关人士对《证券日报》记者表示:"港股经历此轮 ...
基金回报榜:243只基金昨日回报超5%
Zheng Quan Shi Bao Wang· 2025-12-09 01:20
Core Insights - The stock and mixed funds achieved a positive return of 70.27% on December 8, with 243 funds returning over 5% and 472 funds experiencing a net value drawdown exceeding 1% [1][2] Fund Performance - The Shanghai Composite Index rose by 0.54% to close at 3924.08 points, while the Shenzhen Component Index increased by 1.39%, the ChiNext Index by 2.60%, and the STAR 50 Index by 1.86% [1] - The top-performing sectors included telecommunications, comprehensive, and electronics, with increases of 4.79%, 3.03%, and 2.60% respectively. Conversely, coal, oil and petrochemicals, and food and beverage sectors saw declines of 1.43%, 0.84%, and 0.78% respectively [1] - The average net value growth rate for stock and mixed funds on December 8 was 0.80% [1] Top Funds - The fund with the highest net value growth rate was Guorong Rongxin Consumer Select Mixed C, achieving a growth rate of 10.01%. Other notable funds included Guorong Rongxin Consumer Select Mixed A (10.00%), and Guoshou Anbao Strategy Selected Mixed A (9.14%) [2] - Among the funds with a net value growth rate exceeding 5%, 142 were equity funds, 41 were flexible allocation funds, and 34 were index equity funds [2] Drawdown Analysis - A total of 472 funds experienced a drawdown exceeding 1%, with the largest drawdown recorded by Huatai-PB Hong Kong Stock Connect Medical Selected Mixed Initiated C, which saw a decline of 2.40% [2][4] - Other funds with significant drawdowns included Huatai-PB Hong Kong Stock Connect Medical Selected Mixed Initiated A (-2.40%), and Yin Hua Fu Li Selected Mixed C (-2.32%) [4]
越跌越买,资金持续涌入
Zhong Guo Zheng Quan Bao· 2025-11-14 14:06
Group 1: Oil and Gas Sector Performance - The oil and gas sector showed strong performance on November 14, with multiple related ETFs rising over 1% [1] - The leading oil and gas ETF, Bosera Oil and Gas ETF (561760), recorded a gain of 2.02%, while other ETFs like Oil and Gas Resource ETF (159309) and (563150) also saw increases of 1.68% and 1.48% respectively [4][5] - The best-performing sector this week was the innovative drug sector, with several ETFs gaining over 7% in the last five trading days [4] Group 2: Technology Sector Weakness - The technology sector, particularly in subcategories like chips, internet, cloud computing, and AI, experienced significant declines in ETF performance [2][6] - Despite the weak performance of many technology-themed ETFs, there remains a strong inflow of funds into artificial intelligence ETFs, indicating continued investor interest [3][9] Group 3: Fund Inflows and Market Sentiment - Despite the overall weak performance of technology-themed ETFs, there was a notable net inflow of over 1.1 billion yuan into the Southern Growth Enterprise Board AI ETF from November 10 to 13, even as it dropped over 2.6% [9][10] - The top inflow ETFs included Southern Growth Enterprise Board AI ETF with a net inflow of 5.45 billion yuan, and other ETFs like Huatai Golden ETF and ICBC Hong Kong Stock Innovation Drug ETF also saw significant inflows [10] Group 4: Chemical Industry Outlook - The chemical industry is expected to reach an inflection point, with ongoing "anti-involution" self-regulation actions and demand recovery expectations driving strength in the sector [11] - The chemical sector has been in a bottoming phase since early 2023, and with new capacity nearing its end, the industry is poised for improvement in supply-demand dynamics by 2026 [11]
201只ETF获融资净买入 鹏扬中债-30年期国债ETF居首
Sou Hu Cai Jing· 2025-11-07 01:54
Core Viewpoint - As of November 6, the total margin balance for ETFs in the Shanghai and Shenzhen markets is 120.779 billion yuan, showing a decrease of 1.193 billion yuan from the previous trading day [1] Group 1: ETF Financing and Margin Balance - The ETF financing balance stands at 112.351 billion yuan, down by 1.366 billion yuan compared to the previous trading day [1] - The ETF margin short balance is 8.428 billion yuan, which has increased by 0.173 billion yuan from the previous trading day [1] Group 2: Net Buy Insights - On November 6, 201 ETFs experienced net financing purchases, with the Pengyang 30-Year Government Bond ETF leading with a net purchase amount of 0.109 billion yuan [1] - Other ETFs with significant net financing purchases include the Penghua China Securities Wine ETF, Bosera China Securities Convertible Bonds and Exchangeable Bonds ETF, Huatai-PineBridge Hong Kong Stock Connect Innovative Drug ETF, Bosera 30-Year Government Bond ETF, and Invesco Nasdaq Technology Market Cap Weighted ETF [1]
280只ETF获融资净买入 富国中债7—10年政策性金融债ETF居首
Zheng Quan Shi Bao Wang· 2025-11-04 02:08
Core Viewpoint - As of November 3, the total margin balance of ETFs in the Shanghai and Shenzhen markets reached 121.654 billion yuan, reflecting an increase of 2.722 billion yuan from the previous trading day [1] Group 1: ETF Financing and Margin Balances - The ETF financing balance stood at 113.527 billion yuan, up by 2.542 billion yuan compared to the previous trading day [1] - The ETF margin short balance was recorded at 8.127 billion yuan, which is an increase of 180 million yuan from the previous trading day [1] Group 2: Net Inflows in ETFs - On November 3, 280 ETFs experienced net financing inflows, with the top net inflow being the Fortune China Government Bond ETF (7-10 years) at 1.487 billion yuan [1] - Other ETFs with significant net inflows included the Bosera China Government Bond ETF (0-3 years), the Guotai Asset 5-Year Government Bond ETF, and several others focused on innovative pharmaceuticals and technology sectors [1]
ETF规模速报 | 证券ETF净流入超10亿元,上证50ETF净流出超11亿元
Sou Hu Cai Jing· 2025-11-04 01:15
Market Overview - The market rebounded yesterday with all three major indices turning positive, driven by active performance in the photovoltaic sector, a strong coal sector, and continued strength in the Hainan Free Trade Zone [1] - Storage chip concept stocks also showed signs of recovery, while battery concept stocks underperformed [1] ETF Market Activity - On November 3, the non-monetary ETF market saw significant inflows, with the following notable changes: - The Cathay CSI All Share Securities Company ETF saw an increase of 883 million shares and a net inflow of 1.098 billion yuan [1] - The Huatai-PB CSI Hong Kong Stock Connect Innovative Drug ETF increased by 531 million shares with a net inflow of 944 million yuan [1] - The Huatai-PB CSI A500 ETF increased by 738 million shares with a net inflow of 914 million yuan [1] Fund Performance - The top 20 ETFs by net inflow as of November 3 include: - Cathay CSI All Share Securities Company ETF with a net inflow of 1.098 billion yuan and a total fund size of 62.234 billion yuan [4] - Huatai-PB CSI Hong Kong Stock Connect Innovative Drug ETF with a net inflow of 944 million yuan and a total fund size of 21.786 billion yuan [4] - Huatai-PB CSI A500 ETF with a net inflow of 914 million yuan and a total fund size of 26.104 billion yuan [4] Overall ETF Market Statistics - As of November 3, the total ETF market had 31,321.06 billion shares and a total size of 57,204.87 billion yuan [4] - The financial sector saw the largest increase in ETF shares, with 25 funds tracking it [4] - The largest increase in thematic funds was in the CSI Wine Index, with one fund tracking it [4] - The largest increase in index tracking was for securities companies, with 14 funds following this index [4] - The highest return was from the photovoltaic leading 30 index, which rose by 3.87%, with one fund tracking it [4]
最牛,大赚超200%!
Zhong Guo Ji Jin Bao· 2025-11-01 15:38
Core Insights - The A-share market has shown significant recovery in 2025, with the Shanghai Composite Index reaching a 10-year high of 4025.70 points by the end of October, leading to a strong performance of public equity funds and the emergence of numerous "doubling funds" [1][3] Group 1: Fund Performance - The average net value growth rate of actively managed equity funds for the first ten months reached 27.48%, with the best-performing funds exceeding 200% [3][5] - Over 98% of actively managed equity funds reported positive net value growth rates, with 705 funds achieving over 50% growth, and 34 funds surpassing 100% [7][5] - The top-performing fund, Yongying Technology Smart Selection A, achieved a net value growth rate of 200.63%, capitalizing on opportunities in the cloud computing market [9][8] Group 2: Index and Sector Performance - Major indices such as the ChiNext Index and the Science and Technology Innovation 50 Index saw annual growth rates exceeding 50%, with the ChiNext Index at 48.84% [1][4] - The communication equipment sector emerged as a significant winner, with related index funds showing remarkable performance, including the Guotai CSI All-Index Communication Equipment ETF, which had a growth rate of 98.87% [12][13] Group 3: Investment Themes and Manager Insights - Fund managers are focusing on structural opportunities in sectors like AI, innovative drugs, and robotics, which have shown strong performance [7][14] - Investment strategies include a focus on domestic semiconductor equipment and energy storage, with managers highlighting the increasing production capacity of domestic storage chips and the growing demand for energy storage solutions [15][14]
最高近190%!前三季度37只基金收益翻倍!AI主题表现领跑
Sou Hu Cai Jing· 2025-09-30 12:53
Core Viewpoint - The A-share and Hong Kong stock markets have shown a continuous upward trend since mid-April, achieving new highs in the third quarter, with equity funds yielding significant returns [1] Group 1: Active Equity Funds - A total of 37 funds have doubled their returns this year as of September 26, with 31 active equity funds in A-shares achieving over 100% returns [2][4] - The average return for active equity funds is 30.32%, with over 98% of these funds reporting positive returns [4] - The top-performing fund, Yongying Technology Smart Selection A, has a return rate of 189.58%, significantly boosted by its focus on AI concept stocks [4][6] Group 2: Passive Index Funds - Nearly 98% of index funds have achieved positive returns, with an average return of 27.53% [7] - Funds tracking innovative drugs, communications, and artificial intelligence have outperformed, with the top two funds yielding returns of 103.96% and 100.59% [7] - Underperforming index funds are primarily those tracking energy, food and beverage, and coal sectors, with losses exceeding 5% [7] Group 3: QDII Funds - QDII funds focused on the Hong Kong market, particularly in innovative drug assets, have performed well, with four funds exceeding 100% returns [3][8] - The top-performing QDII fund, Huatai Bairui Hang Seng Innovation Drug ETF, has a return of 152.25% [8] - Other notable funds in this category have also shown strong performance, with several exceeding 90% returns [8]